标题
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-16
出版商
Hindawi Limited
发表日期
2015-10-29
DOI
10.1155/2015/102476
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management
- (2015) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis
- (2015) Fiorella Ciaffoni et al. BLOOD CELLS MOLECULES AND DISEASES
- Mechanisms of thrombogenesis in polycythemia vera
- (2015) Michael H. Kroll et al. BLOOD REVIEWS
- The role of nonrandomized trials in the evaluation of oncology drugs
- (2015) R Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Smoking and philadelphia-negative chronic myeloproliferative neoplasms
- (2015) Anders Lindholm Sørensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis
- (2015) Hans Carl Hasselbalch EUROPEAN JOURNAL OF HAEMATOLOGY
- High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms
- (2015) Anneli Enblom et al. European Journal of Internal Medicine
- Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
- (2015) Cecilie Utke Rank et al. LEUKEMIA & LYMPHOMA
- Smoking as a contributing factor for development of polycythemia vera and related neoplasms
- (2015) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Fibrosis — A Common Pathway to Organ Injury and Failure
- (2015) Don C. Rockey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?
- (2015) Hans Carl Hasselbalch et al. Expert Review of Hematology
- Bone morbidity in chronic myeloproliferative neoplasms
- (2015) Sarah Farmer et al. Expert Review of Hematology
- Tumors: Wounds That Do Not Heal--Redux
- (2015) H. F. Dvorak Cancer Immunology Research
- Occurrence of theJAK2 V617Fmutation in patients with peripheral arterial disease
- (2014) Axel Muendlein et al. AMERICAN JOURNAL OF HEMATOLOGY
- How I treat polycythemia vera
- (2014) A. M. Vannucchi BLOOD
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms
- (2014) M. Cazzola et al. BLOOD
- Comorbidities predict worse prognosis in patients with primary myelofibrosis
- (2014) Kate J. Newberry et al. CANCER
- Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state
- (2014) Mads Emil Bjørn et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
- (2014) Helna Pettersson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expansion of circulating CD56brightnatural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
- (2014) Caroline H. Riley et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials
- (2014) J. Mascarenhas et al. HAEMATOLOGICA
- Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms
- (2014) Alexander Sidelmann Christensen et al. LEUKEMIA RESEARCH
- Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat
- (2014) Christen Lykkegaard Andersen et al. LEUKEMIA RESEARCH
- The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
- (2014) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation
- (2014) Hans Carl Hasselbalch et al. PLoS One
- Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression
- (2014) Hans Carl Hasselbalch et al. PLoS One
- Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms
- (2014) Hans C Hasselbalch Expert Review of Hematology
- An Immune Dysregulation in MPN
- (2014) Giovanni Barosi Current Hematologic Malignancy Reports
- Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management
- (2013) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Evaluation of the prevalence and prospective clinical impact of theJAK2 V617Fmutation in coronary patients
- (2013) Axel Muendlein et al. AMERICAN JOURNAL OF HEMATOLOGY
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
- Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study
- (2013) Sarah Farmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- The role of cytokines in the initiation and progression of myelofibrosis
- (2013) Hans C. Hasselbalch CYTOKINE & GROWTH FACTOR REVIEWS
- Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
- (2013) T Barbui et al. LEUKEMIA
- Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib
- (2013) M Massa et al. LEUKEMIA
- Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis
- (2013) Vibe Skov et al. LEUKEMIA & LYMPHOMA
- Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns
- (2013) Wilma Barcellini et al. LEUKEMIA RESEARCH
- Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha
- (2013) Thomas Stauffer Larsen et al. LEUKEMIA RESEARCH
- A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?
- (2013) Hans C. Hasselbalch LEUKEMIA RESEARCH
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2 Mutation-Related Disease and Thrombosis
- (2013) Paola Guglielmelli et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
- (2013) Richard T Silver et al. Expert Review of Hematology
- Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
- (2012) Rakhee Vaidya et al. AMERICAN JOURNAL OF HEMATOLOGY
- How I treat polycythemia vera
- (2012) F. Passamonti BLOOD
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth
- (2012) Lori N. Griner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnostic value ofJAK2V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population
- (2012) Camilla Nielsen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
- (2012) Hans Carl Hasselbalch et al. CURRENT DRUG TARGETS
- Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
- (2012) Vibe Skov et al. EXPERIMENTAL HEMATOLOGY
- A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
- (2012) Kai B. Kaufmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
- (2012) Vibe Skov et al. LEUKEMIA RESEARCH
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
- (2011) H. Frederiksen et al. BLOOD
- Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-
- (2011) C. H. Riley et al. BLOOD
- Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
- (2011) Vibe Skov et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hydroxycarbamide: a user’s guide for chronic myeloproliferative disorders
- (2011) Jerry L Spivak et al. Expert Review of Anticancer Therapy
- The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?
- (2011) S. Hermouet et al. HAEMATOLOGICA
- Pathophysiology of thrombosis in myeloproliferative neoplasms
- (2011) R. Landolfi et al. HAEMATOLOGICA
- Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
- (2011) Hans Carl Hasselbalch et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2011) Sigurdur Y. Kristinsson et al. JOURNAL OF CLINICAL ONCOLOGY
- How to manage polycythemia vera
- (2011) F Passamonti LEUKEMIA
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
- (2011) Hans Carl Hasselbalch Expert Review of Hematology
- Molecular pathways and targets in cancer-related inflammation
- (2010) Alberto Mantovani et al. ANNALS OF MEDICINE
- Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke
- (2010) Zechariah G. Franks et al. Annals of the New York Academy of Sciences
- Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: A cancer registry-based analysis in the south of the Netherlands
- (2010) Saskia A.M. van de Schans et al. AUTOIMMUNITY REVIEWS
- How I treat essential thrombocythemia
- (2010) P. A. Beer et al. BLOOD
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
- (2010) T. Barbui et al. HAEMATOLOGICA
- Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
- (2010) Giovanni Barosi et al. LEUKEMIA RESEARCH
- Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population
- (2010) Lynnette R. Ferguson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
- (2009) Young Hee Rho et al. ARTHRITIS AND RHEUMATISM
- Risks of myeloid malignancies in patients with autoimmune conditions
- (2009) L A Anderson et al. BRITISH JOURNAL OF CANCER
- More than skin deep: atherosclerosis as a systemic manifestation of psoriasis
- (2009) A.B. Alexandroff et al. BRITISH JOURNAL OF DERMATOLOGY
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
- (2009) Thomas Stauffer Larsen et al. Hematology
- Autoimmunity and hematologic malignancies: associations and mechanisms
- (2009) Damali N. Martin et al. LEUKEMIA & LYMPHOMA
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- (2009) Damla Olcaydu et al. NATURE GENETICS
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence
- (2008) J.-J. Lataillade et al. BLOOD
- Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update
- (2008) K. E. Smedby et al. JOURNAL OF INTERNAL MEDICINE
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
- Myelofibrosis with myeloid metaplasia: The advanced phase of an untreated disseminated hematological cancer
- (2008) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
- (2008) Jeffrey C Barrett et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search